RecruitingNot ApplicableNCT05874141

Comorbidities in Type 2 Diabetes Mellitus

Comorbidities in Type 2 Diabetes Mellitus: An Observational Study in Kharga City, New Valley Governate, Egypt


Sponsor

New Valley University

Enrollment

288 participants

Start Date

Nov 15, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Type 2 diabetes mellitus (DM) has adopted a top priority as it is a disease with an increasing prevalence. The number of people living with DM has increased more than fourfold over the past 40 years to more than 460 million people today


Eligibility

Min Age: 18 YearsMax Age: 90 Years

Inclusion Criteria1

  • Patients with type 2 diabetes.

Exclusion Criteria2

  • Patients with type 1 diabetes.
  • Patients with secondary diabetes.

Interventions

DIAGNOSTIC_TESTHBA1C

blood sample on EDTA

DIAGNOSTIC_TESTLipid profile, including total, LDL, and HDL cholesterol and Triglycerides

serum sample

DIAGNOSTIC_TESTUrine analysis and urinary albumin-to-creatinine ratio

Morning urine sample

DIAGNOSTIC_TESTSerum creatinine and estimated glomerular filtration rate

serum sample

DIAGNOSTIC_TESTComplete blood count

blood sample on EDTA

DIAGNOSTIC_TESTThyroid-stimulating hormone

serum sample

DIAGNOSTIC_TESTSerum iron, TIBC, Transferrin saturation and serum ferritin if needed

serum sample

PROCEDUREElectrocardiography (ECG)

by electrocardiogram

PROCEDURETransthoracic echocardiography, Neck ultrasonography if needed and abdominopelvic ultrasound

imaging

PROCEDUREArterial duplex ultrasound of both lower limbs

imaging

DIAGNOSTIC_TESTRandom blood glucose

serum sample

DIAGNOSTIC_TESTAST, ALT, albumin

serum sample


Locations(1)

New Valley University

Al Khārjah, Kharga Oasis, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05874141


Related Trials